Works matching AU Bergsagel, Leif

Results: 64
    1

    Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma.

    Published in:
    OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1008850
    By:
    • Calcinotto, Arianna;
    • Ponzoni, Maurilio;
    • Ria, Roberto;
    • Grioni, Matteo;
    • Cattaneo, Elena;
    • Villa, Isabella;
    • Bertilaccio, Maria Teresa Sabrina;
    • Chesi, Marta;
    • Rubinacci, Alessandro;
    • Tonon, Giovanni;
    • Bergsagel, P Leif;
    • Vacca, Angelo;
    • Bellone, Matteo
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8

    Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma.

    Published in:
    British Journal of Haematology, 2022, v. 199, n. 1, p. 95, doi. 10.1111/bjh.18298
    By:
    • Abeykoon, Jithma P.;
    • Vaxman, Julia;
    • Patel, Sanjay V.;
    • Kumar, Shaji;
    • Malave, Gabriella C.;
    • Young, Kimberly S.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy T.;
    • Dispenzieri, Angela;
    • Muchtar, Eli;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Leung, Nelson;
    • Warsame, Rahma;
    • Go, Ronald S.;
    • Bergsagel, Leif;
    • Lacy, Martha Q.;
    • Rajkumar, S. Vincent;
    • Gertz, Morie A.;
    • Kapoor, Prashant
    Publication type:
    Article
    9

    Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01310-z
    By:
    • Parrondo, Ricardo D.;
    • Das, Saurav;
    • Sledge, Hanna;
    • Bergsagel, Leif;
    • Fonseca, Rafael;
    • Leung, Nelson;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Elliott, Jamie;
    • Fernandez, Andre;
    • Flott, Caitlin;
    • Chanan-Khan, Asher A.;
    • Roy, Vivek;
    • Ailawadhi, Sikander
    Publication type:
    Article
    10

    Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 6, p. 456, doi. 10.1016/j.clml.2023.03.002
    By:
    • Wiedmeier-Nutor, Julia E.;
    • Iqbal, Madiha;
    • Rosenthal, Allison C.;
    • Bezerra, Evandro D.;
    • Garcia-Robledo, Juan Esteban;
    • Bansal, Radhika;
    • Johnston, Patrick B.;
    • Hathcock, Matthew;
    • Larsen, Jeremy T.;
    • Leif Bergsagel, P.;
    • Wang, Yucai;
    • Reeder, Craig B.;
    • Leis, Jose F.;
    • Fonseca, Rafael;
    • Palmer, Jeanne M.;
    • Gysbers, Brianna J.;
    • Mwangi, Raphael;
    • Warsame, Rahma M.;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.
    Publication type:
    Article
    11

    Mate pair sequencing outperforms fluorescence in situ hybridization and improves diagnostic yield in the genomic characterization of multiple myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e58, doi. 10.1016/j.clml.2019.09.090
    By:
    • Baughn, Linda;
    • James, Smadbeck;
    • Kathryn, Pearce;
    • Pitel, Beth;
    • Timm, Michael;
    • Bergsagel, Leif;
    • Jevremovic, Dragan;
    • Shi, Min;
    • Stewart, Keith;
    • Braggio, Esteban;
    • Riggs, Daniel;
    • George, Vasmatzis;
    • Kearney, Hutton;
    • Hoppman, Nicole;
    • Ketterling, Rhett;
    • Greipp, Patricia;
    • Kumar, Shaji;
    • Rajkumar, S.Vincent;
    • Peterson, Jess
    Publication type:
    Article
    12
    13
    14

    Signaling Pathways in Myeloma.

    Published in:
    Clinical Lymphoma & Myeloma, 2009, v. 9, p. S12
    By:
    • Hideshima, Teru;
    • Mitsiades, Constantine S.;
    • Stewart, A. Keith;
    • Bergsagel, P. Leif;
    • Klein, Bernard
    Publication type:
    Article
    15
    16
    17
    18

    Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression.

    Published in:
    Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-07305-8
    By:
    • Calcinotto, Arianna;
    • Brevi, Arianna;
    • Chesi, Marta;
    • Ferrarese, Roberto;
    • Garcia Perez, Laura;
    • Grioni, Matteo;
    • Kumar, Shaji;
    • Garbitt, Victoria M.;
    • Sharik, Meaghen E.;
    • Henderson, Kimberly J.;
    • Tonon, Giovanni;
    • Tomura, Michio;
    • Miwa, Yoshihiro;
    • Esplugues, Enric;
    • Flavell, Richard A.;
    • Huber, Samuel;
    • Canducci, Filippo;
    • Rajkumar, Vincent S.;
    • Bergsagel, P. Leif;
    • Bellone, Matteo
    Publication type:
    Article
    19
    20

    Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair.

    Published in:
    Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0495-y
    By:
    • López-Iglesias, Ana-Alicia;
    • Herrero, Ana B.;
    • Chesi, Marta;
    • San-Segundo, Laura;
    • González-Méndez, Lorena;
    • Hernández-García, Susana;
    • Misiewicz-Krzeminska, Irena;
    • Quwaider, Dalia;
    • Martín-Sánchez, Montserrat;
    • Primo, Daniel;
    • Paíno, Teresa;
    • Bergsagel, P. Leif;
    • Mehrling, Thomas;
    • González-Díaz, Marcos;
    • San-Miguel, Jesús F.;
    • Mateos, María-Victoria;
    • Gutiérrez, Norma C.;
    • Garayoa, Mercedes;
    • Ocio, Enrique M.
    Publication type:
    Article
    21
    22

    Immunosurveillance and therapy of multiple myeloma are CD226 dependent.

    Published in:
    2015
    By:
    • Guillerey, Camille;
    • Ferrari de Andrade, Lucas;
    • Vuckovic, Slavica;
    • Miles, Kim;
    • Ngiow, Shin Foong;
    • Yong, Michelle C R;
    • Teng, Michele W L;
    • Colonna, Marco;
    • Ritchie, David S;
    • Chesi, Martha;
    • Bergsagel, P Leif;
    • Hill, Geoffrey R;
    • Smyth, Mark J;
    • Martinet, Ludovic;
    • Chesi, Marta
    Publication type:
    journal article
    23

    Immunosurveillance and therapy of multiple myeloma areCD226 dependent.

    Published in:
    Journal of Clinical Investigation, 2015, v. 125, n. 5, p. 2077, doi. 10.1172/JCI77181
    By:
    • Guillerey, Camille;
    • Ferrari de Andrade, Lucas;
    • Vuckovic, Slavica;
    • Miles, Kim;
    • Shin Foong Ngiow;
    • Yong, Michelle C. R.;
    • Teng, Michele W. L.;
    • Colonna, Marco;
    • Ritchie, David S.;
    • Chesi, Martha;
    • Bergsagel, P. Leif;
    • Hill, Geoffrey R.;
    • Smyth, MarkJ.;
    • Martinet, Ludovic
    Publication type:
    Article
    24
    25
    26
    27

    Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0255-z
    By:
    • Smadbeck, James;
    • Peterson, Jess F.;
    • Pearce, Kathryn E.;
    • Pitel, Beth A.;
    • Figueroa, Andrea Lebron;
    • Timm, Michael;
    • Jevremovic, A. Dragan;
    • Shi, Min;
    • Stewart, A. Keith;
    • Braggio, Esteban;
    • Riggs, Daniel L.;
    • Bergsagel, P. Leif;
    • Vasmatzis, George;
    • Kearney, Hutton M.;
    • Hoppman, Nicole L.;
    • Ketterling, Rhett P.;
    • Kumar, Shaji;
    • Rajkumar, S. Vincent;
    • Greipp, Patricia T.;
    • Baughn, Linda B.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma.

    Published in:
    British Journal of Haematology, 2012, v. 156, n. 3, p. 326, doi. 10.1111/j.1365-2141.2011.08949.x
    By:
    • Khan, Meaghan L.;
    • Reeder, Craig B.;
    • Kumar, Shaji K.;
    • Lacy, Marthy Q.;
    • Reece, Donna E.;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Greipp, Phillip;
    • Hayman, Suzanne;
    • Zeldenhurst, Steven;
    • Dingli, David;
    • Lust, John;
    • Russell, Stephen;
    • Laumann, Kristina M.;
    • Mikhael, Joseph R.;
    • Leif Bergsagel, P.;
    • Fonseca, Rafael;
    • Vincent Rajkumar, S.;
    • Keith Stewart, A.
    Publication type:
    Article
    34
    35
    36
    37
    38

    Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease.

    Published in:
    Science Translational Medicine, 2019, v. 11, n. 494, p. 1, doi. 10.1126/scitranslmed.aau9087
    By:
    • Liu, Huan;
    • He, Jin;
    • Koh, Su Pin;
    • Zhong, Yuping;
    • Liu, Zhiqiang;
    • Wang, Zhiqiang;
    • Zhang, Yujin;
    • Li, Zongwei;
    • Tam, Bjorn T.;
    • Lin, Pei;
    • Xiao, Min;
    • Young, Ken H.;
    • Amini, Behrang;
    • Starbuck, Michael W.;
    • Lee, Hans C.;
    • Navone, Nora M.;
    • Davis, Richard E.;
    • Tong, Qiang;
    • Bergsagel, P. Leif;
    • Hou, Jian
    Publication type:
    Article
    39

    Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01264-2
    By:
    • Bolarinwa, Abiola;
    • Nagaraj, Madhu;
    • Zanwar, Saurabh;
    • Abdallah, Nadine;
    • Bergsagel, P. Leif;
    • Binder, Moritz;
    • Buadi, Francis;
    • Chhabra, Saurabh;
    • Cook, Joselle;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Leung, Nelson;
    • Lin, Yi;
    • Muchtar, Eli;
    • Parrondo, Ricardo
    Publication type:
    Article
    40

    Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention.

    Published in:
    Blood Cancer Journal, 2025, v. 14, n. 1, p. 1, doi. 10.1038/s41408-025-01215-x
    By:
    • Fonseca, Rodrigo;
    • Zhu, Yuan Xiao;
    • Bruins, Laura A.;
    • Ahmann, Joseph;
    • de Bonolo Campos, Cecilia;
    • Braggio, Esteban;
    • Chen, Xianfeng;
    • Arribas, Mariano;
    • Darvish, Susie;
    • Welsh, Seth;
    • Meermeier, Erin;
    • Mangalaparthi, Kiran K.;
    • Kandasamy, Richard K.;
    • Ahmann, Greg;
    • Wiedmeier-Nutor, J. Erin;
    • Pandey, Akhilesh;
    • Chesi, Marta;
    • Bergsagel, P. Leif;
    • Fonseca, Rafael
    Publication type:
    Article
    41

    Mode of progression in smoldering multiple myeloma: a study of 406 patients.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00980-5
    By:
    • Abdallah, Nadine H.;
    • Lakshman, Arjun;
    • Kumar, Shaji K.;
    • Cook, Joselle;
    • Binder, Moritz;
    • Kapoor, Prashant;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Lacy, Martha Q.;
    • Hayman, Suzanne R.;
    • Buadi, Francis K.;
    • Dingli, David;
    • Lin, Yi;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Bergsagel, Leif;
    • Rajkumar, S. Vincent
    Publication type:
    Article
    42
    43

    Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
    By:
    • Baughn, Linda B.;
    • Jessen, Erik;
    • Sharma, Neeraj;
    • Tang, Hongwei;
    • Smadbeck, James B.;
    • Long, Mark D.;
    • Pearce, Kathryn;
    • Smith, Matthew;
    • Dasari, Surendra;
    • Sachs, Zohar;
    • Linden, Michael A.;
    • Cook, Joselle;
    • Keith Stewart, A.;
    • Chesi, Marta;
    • Mitra, Amit;
    • Leif Bergsagel, P.;
    • Van Ness, Brian;
    • Kumar, Shaji K.
    Publication type:
    Article
    44

    Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
    By:
    • Bansal, Radhika;
    • Baksh, Mizba;
    • Larsen, Jeremy T.;
    • Hathcock, Matthew A.;
    • Dingli, David;
    • Stewart, A. Keith;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.;
    • Warsame, Rahma M.;
    • Fonseca, Rafael;
    • Bergsagel, P. Leif;
    • Ailawadhi, Sikander;
    • Kumar, Shaji K.;
    • Lin, Yi
    Publication type:
    Article
    45

    Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
    By:
    • Fonseca, Rodrigo;
    • Arribas, Mariano;
    • Wiedmeier-Nutor, Julia E.;
    • Kusne, Yael N.;
    • González Vélez, Miguel;
    • Kosiorek, Heidi E.;
    • Butterfield, Richard J.;
    • Kirsch, Ilan R.;
    • Mikhael, Joseph R.;
    • Stewart, A. Keith;
    • Reeder, Craig;
    • Larsen, Jeremy;
    • Bergsagel, P. Leif;
    • Fonseca, Rafael
    Publication type:
    Article
    46

    Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00851-5
    By:
    • Baughn, Linda B.;
    • Jessen, Erik;
    • Sharma, Neeraj;
    • Tang, Hongwei;
    • Smadbeck, James B.;
    • Long, Mark D.;
    • Pearce, Kathryn;
    • Smith, Matthew;
    • Dasari, Surendra;
    • Sachs, Zohar;
    • Linden, Michael A.;
    • Cook, Joselle;
    • Keith Stewart, A.;
    • Chesi, Marta;
    • Mitra, Amit;
    • Leif Bergsagel, P.;
    • Van Ness, Brian;
    • Kumar, Shaji K.
    Publication type:
    Article
    47

    Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00820-y
    By:
    • Bansal, Radhika;
    • Baksh, Mizba;
    • Larsen, Jeremy T.;
    • Hathcock, Matthew A.;
    • Dingli, David;
    • Stewart, A. Keith;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Hayman, Suzanne R.;
    • Warsame, Rahma M.;
    • Fonseca, Rafael;
    • Bergsagel, P. Leif;
    • Ailawadhi, Sikander;
    • Kumar, Shaji K.;
    • Lin, Yi
    Publication type:
    Article
    48

    Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00794-x
    By:
    • Fonseca, Rodrigo;
    • Arribas, Mariano;
    • Wiedmeier-Nutor, Julia E.;
    • Kusne, Yael N.;
    • González Vélez, Miguel;
    • Kosiorek, Heidi E.;
    • Butterfield, Richard J.;
    • Kirsch, Ilan R.;
    • Mikhael, Joseph R.;
    • Stewart, A. Keith;
    • Reeder, Craig;
    • Larsen, Jeremy;
    • Bergsagel, P. Leif;
    • Fonseca, Rafael
    Publication type:
    Article
    49

    Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00752-z
    By:
    • Zanwar, Saurabh;
    • Ho, Matthew;
    • Buadi, Francis K.;
    • Ailawadhi, Sikander;
    • Larsen, Jeremy;
    • Bergsagel, Leif;
    • Binder, Moritz;
    • Chanan-Khan, Asher;
    • Dingli, David;
    • Dispenzieri, Angela;
    • Fonseca, Rafael;
    • Gertz, Morie A.;
    • Gonsalves, Wilson;
    • Go, Ronald S.;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Kourelis, Taxiarchis;
    • Lacy, Martha Q.;
    • Leung, Nelson;
    • Lin, Yi
    Publication type:
    Article
    50